GSK
Director, Oncology Early Translational Biomarkers
$190K–$316K
USA - Massachusetts - Waltham · Hybrid (Remote & On-site) · Director · Full-time · Posted Oct 26, 2026
- Experience
- Minimum 5 years; no stated alternatives.
- Education
- PhD and/or MD.
About the job
Leads biomarker and translational medicine strategy and delivery for early oncology programs, from preclinical research through Phase 1, to guide patient selection and development decisions.
What you'll do
- Own translational biomarker plans, assays, and decision-enabling data across assigned early oncology programs.
- Lead clinical biomarker implementation and coordinate cross-functional teams, external partners, and program governance.
- Interpret evidence and communicate recommendations, reports, and presentations; mentor junior scientists.
What they ask for
- PhD and/or MD with substantive experience in Oncology or immune-Oncology drug development.
- At least 5 years in translational medicine, biomarker science, or clinical development, particularly applying biomarkers in Oncology clinical trials in pharmaceutical or biotechnology industry.
- Expertise in cancer biology and multiple therapeutic modalities, including large molecules, small molecules, and immune cell engagers.
- Track record designing and executing biomarker strategies in clinical trials; hands-on experience with platforms including flow cytometry, NGS, FISH, PCR, and/or IHC/IF.
Nice to have
- Experience with CTD/ctDNA platforms and liquid biopsy approaches.
- Digital pathology and AI/ML integration experience for biomarker analyses.
Pay
USD 189,750 to USD 316,250 annual base salary
Tools
flow cytometry, NGS, FISH, PCR, IHC/IF, CTD/ctDNA, Digital pathology, AI/ML
AI focus
Preferred experience integrating AI/ML with digital pathology for biomarker analyses.
Model-written summary · the original posting is authoritative